NC DHHS / NC Medicaid preferred drug list update, 2025 The NC State Health Plan, covering public employees and teachers, dropped weight-loss GLP-1 coverage in 2024 due to projected cost growth
This allows individuals to access proven GLP-1 therapy without paying premium prices for brand recognition
The medication follows a specific pharmacokinetic pattern, and aligning your meals with that pattern improves both results and comfort
Observations on IGF-1 and Downstream Signals Some studies have reported that stimulation with CJC-1295 may be linked with increases in insulin-like growth factor 1 (IGF-1), a mediator associated with growth hormone activity
These alternative pathways highlight the need for further functional studies to delineate the exact mechanisms underlying the observed associations
In line with the present findings, Wei et al